KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Other Non Operating Income: 2010-2024

Historic Other Non Operating Income for Emergent BioSolutions (EBS) over the last 15 years, with Dec 2024 value amounting to $12.5 million.

  • Emergent BioSolutions' Other Non Operating Income fell 116.89% to -$3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.0 million, marking a year-over-year increase of 120.15%. This contributed to the annual value of $12.5 million for FY2024, which is 40.45% up from last year.
  • Emergent BioSolutions' Other Non Operating Income amounted to $12.5 million in FY2024, which was up 40.45% from $8.9 million recorded in FY2023.
  • Emergent BioSolutions' Other Non Operating Income's 5-year high stood at $12.5 million during FY2024, with a 5-year trough of -$11.7 million in FY2022.
  • Over the past 3 years, Emergent BioSolutions' median Other Non Operating Income value was $8.9 million (recorded in 2023), while the average stood at $3.2 million.
  • As far as peak fluctuations go, Emergent BioSolutions' Other Non Operating Income skyrocketed by 176.47% in 2020, and later tumbled by 216.22% in 2022.
  • Yearly analysis of 5 years shows Emergent BioSolutions' Other Non Operating Income stood at $4.7 million in 2020, then tumbled by 178.72% to -$3.7 million in 2021, then tumbled by 216.22% to -$11.7 million in 2022, then spiked by 176.07% to $8.9 million in 2023, then spiked by 40.45% to $12.5 million in 2024.